{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:56Z","timestamp":1786119176025,"version":"build-2736575974"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/gco.0b013e3282efdc54","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T17:57:14Z","timestamp":1236189434000},"page":"420-426","source":"Crossref","is-referenced-by-count":16,"title":["Polycystic ovarian syndrome in adolescents"],"prefix":"10.1097","volume":"19","author":[{"given":"George","family":"Creatsas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios","family":"Deligeoroglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210129","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.ogx.0000197817.93201.04","article-title":"Polycystic ovary syndrome and its differential diagnosis","volume":"61","author":"Lane","year":"2006","journal-title":"Obstet Gynecol Surv"},{"issue":"Suppl 1","key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.fertnstert.2006.03.012","article-title":"Diagnosis, phenotype, and prevalence of polycystic ovary syndrome","volume":"86","author":"Carmina","year":"2006","journal-title":"Fertil Steril"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/humrep\/12.12.2641","article-title":"The genetic basis of polycystic ovary syndrome","volume":"12","author":"Franks","year":"1997","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"R5-4-20210129","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.fertnstert.2006.04.015","article-title":"Clinical expression of polycystic ovary syndrome in adolescent girls","volume":"86","author":"Sultan","year":"2006","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"R6-4-20210129","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.fertnstert.2006.04.016","article-title":"Candidate genes in women with polycystic ovary syndrome","volume":"86","author":"Franks","year":"2006","journal-title":"Fertil Steril"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jc.2004-2485","article-title":"Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits","volume":"90","author":"Powell","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-4-20210129","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/BF03347535","article-title":"Presence of metabolic risk factors in nonobese PCOS sisters: evidence of heritability of insulin resistance","volume":"27","author":"Diamanti-Kandarakis","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"Suppl 1","key":"R9-4-20210129","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.fertnstert.2006.03.013","article-title":"Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome","volume":"86","author":"De Zegher","year":"2006","journal-title":"Fertil Steril"},{"key":"R10-4-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of the polycystic ovary syndrome (PCOS) clinical and biochemical characterization of the major clinical subgroups","volume":"83","author":"Chang","year":"2005","journal-title":"Fertil Steril"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.14310\/horm.2002.11176","article-title":"Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome","volume":"5","author":"Alexandraki","year":"2006","journal-title":"Hormones (Athens)"},{"key":"R13-4-20210129","first-page":"1158","article-title":"Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries","volume":"79","author":"Gilling-Smith","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gyobfe.2003.10.027","article-title":"The polycystic ovarian syndrome during the peripubertal period: clinical, biological, metabolic and genetic polymorphisms [in French]","volume":"32","author":"Trim\u00e8che","year":"2004","journal-title":"Gynecol Obstet Fertil"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic\u2013pituitary axis in women with polycystic ovarian disease indirect evidence for partial gonadotroph desensitisation","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-4-20210129","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome","volume":"82","author":"Taylor","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2003-031600","article-title":"Polycystic ovarian morphology with regular ovulatory cycles insights into the pathophysiology of polycystic ovarian syndrome","volume":"89","author":"Adams","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"R18-4-20210129","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.fertnstert.2006.05.001","article-title":"Gonadotropin dysfunction in women with polycystic ovary syndrome","volume":"86","author":"Taylor","year":"2006","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.fertnstert.2006.03.015","article-title":"Ovarian enzyme activities in women with polycystic ovary syndrome","volume":"86","author":"Magoffin","year":"2006","journal-title":"Fertil Steril"},{"key":"R20-4-20210129","first-page":"1318","article-title":"Luteinizing hormone receptor, steroidogenesis acute regulatory protein and steroidogenic enzyme messenger ribonucleic acids are overexpressed in theca and granulosa cells from polycystic ovaries","volume":"86","author":"Jakimiuk","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-4-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/molehr\/4.1.1","article-title":"Aromatase messenger ribonucleic acid expression in individual follicles from polycystic ovaries","volume":"4","author":"Jakimiuk","year":"1998","journal-title":"Mol Hum Reprod"},{"key":"R22-4-20210129","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyper-insulinism, and ovarian hyperandrogenism in girls relation to reduced fetal growth","volume":"83","author":"Ib\u00e1\u00f1ez","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-4-20210129","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-2265.2003.01728.x","article-title":"Fat distribution in nonobese girls with and without precocious pubarche central adiposity related to insulinemia and androgenemia from prepuberty to postmenarche","volume":"58","author":"Ib\u00e1\u00f1ez","year":"2003","journal-title":"Clin Endocrinol"},{"key":"R24-4-20210129","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1210\/jc.2005-2778","article-title":"Early development of adiposity and insulin resistance following catch-up weight gain in small-for-gestational-age children","volume":"91","author":"Ib\u00e1\u00f1ez","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-4-20210129","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1210\/jc.2005-0049","article-title":"Neutrophil count in small-for-gestational-age children contrasting effects of metformin and growth hormone therapy","volume":"90","author":"Ib\u00e1\u00f1ez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-4-20210129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1542\/peds.2005-0664","article-title":"Early puberty-menarche after precocious pubarche relation to prenatal growth","volume":"117","author":"Ib\u00e1\u00f1ez","year":"2006","journal-title":"Pediatrics"},{"key":"R27-4-20210129","first-page":"2691","article-title":"Anovulation after precocious pubarche early markers and time course in adolescence","volume":"84","author":"Ib\u00e1\u00f1ez","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-4-20210129","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-4-20210129","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-4-20210129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"R31-4-20210129","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/jc.2004-0229","article-title":"Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome","volume":"90","author":"Ehrmann","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"R32-4-20210129","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.fertnstert.2006.04.010","article-title":"Type 2 diabetes and polycystic ovary syndrome","volume":"86","author":"Legro","year":"2006","journal-title":"Fertil Steril"},{"key":"R33-4-20210129","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-020363","article-title":"Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS effects of serine kinase inhibitors and IR activators","volume":"87","author":"Li","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"R34-4-20210129","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.fertnstert.2006.04.011","article-title":"Insulin resistance in women with polycystic ovary syndrome","volume":"86","author":"Dunaif","year":"2006","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"R35-4-20210129","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.fertnstert.2006.04.013","article-title":"Metabolic syndrome in women with polycystic ovary syndrome","volume":"86","author":"Essah","year":"2006","journal-title":"Fertil Steril"},{"key":"R36-4-20210129","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0015-0282(03)00347-9","article-title":"The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women a controlled community-based study","volume":"79","author":"Korhonen","year":"2003","journal-title":"Fertil Steril"},{"key":"R37-4-20210129","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"Clin Endocrinol Metab"},{"key":"R38-4-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","author":"Dokras","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R39-4-20210129","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"R40-4-20210129","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/humrep\/dei100","article-title":"Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome","volume":"20","author":"Vural","year":"2005","journal-title":"Hum Reprod"},{"key":"R41-4-20210129","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-4-20210129","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"key":"R43-4-20210129","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jc.2003-032049","article-title":"The cardiovascular risk of young women with polycystic ovary syndrome an observational, analytical, prospective case\u2013control study","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-4-20210129","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0889-8529(05)70079-7","article-title":"Cardiovascular consequences of polycystic ovary syndrome","volume":"28","author":"Amowitz","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R45-4-20210129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2004-0628","article-title":"The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome","volume":"90","author":"Orio","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-4-20210129","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1210\/jc.2004-0276","article-title":"Insulin resistance syndrome in children","volume":"89","author":"Ten","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-4-20210129","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2165\/00148581-200608050-00004","article-title":"Polycystic ovary syndrome in adolescents: current and future treatment options","volume":"8","author":"Mastorakos","year":"2006","journal-title":"Pediatr Drugs"},{"key":"R49-4-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/humrep\/16.1.36","article-title":"Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome","volume":"16","author":"Falsetti","year":"2001","journal-title":"Hum Reprod"},{"key":"R50-4-20210129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/09513598909152466","article-title":"Effects of a low-dose estrogen\u2013antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome","volume":"3","author":"Prelevic","year":"1989","journal-title":"Gynecol Endocrinol"},{"key":"R51-4-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1749-6632.2000.tb06236.x","article-title":"Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile","volume":"900","author":"Creatsas","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"R52-4-20210129","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"72","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"key":"R53-4-20210129","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertil Steril"},{"key":"R54-4-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","article-title":"Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome","volume":"85","author":"Mastorakos","year":"2006","journal-title":"Fertil Steril"},{"key":"R55-4-20210129","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ecl.2005.04.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"34","author":"Buggs","year":"2005","journal-title":"Endocrinol Metab Clin N Am"},{"key":"R56-4-20210129","first-page":"25","article-title":"Low-dose flutamide (125 mg\/day) as maintenance therapy in the treatment of hirsutism","volume":"56","author":"Venturoli","year":"2001","journal-title":"Horm Res"},{"key":"R57-4-20210129","first-page":"233","article-title":"A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women","volume":"80","author":"Wong","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R58-4-20210129","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0015-0282(99)00633-0","article-title":"Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism","volume":"73","author":"Tartagni","year":"2000","journal-title":"Fertil Steril"},{"key":"R59-4-20210129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/09513590009167712","article-title":"Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism","volume":"14","author":"De Leo","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"R60-4-20210129","first-page":"321","article-title":"Polycystic ovary syndrome","volume":"10","author":"Kahn","year":"1999","journal-title":"Adolesc Med"},{"key":"R61-4-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/gye.16.3.217.224","article-title":"Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome","volume":"16","author":"Loverro","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"R62-4-20210129","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaird glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-4-20210129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0015-0282(00)01675-7","article-title":"Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone","volume":"75","author":"Vandermolen","year":"2001","journal-title":"Fertil Steril"},{"key":"R64-4-20210129","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1054-139X(01)00202-6","article-title":"Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS)","volume":"29","author":"Glueck","year":"2001","journal-title":"J Adolesc Health"},{"key":"R65-4-20210129","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.fertnstert.2003.08.024","article-title":"Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome","volume":"81","author":"Belli","year":"2004","journal-title":"Fertil Steril"},{"key":"R66-4-20210129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2004-1376","article-title":"Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance","volume":"90","author":"Sepilian","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R67-4-20210129","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"key":"R68-4-20210129","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.metabol.2005.10.011","article-title":"Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome","volume":"55","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Metabolism"},{"key":"R69-4-20210129","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1001\/jama.289.14.1805","article-title":"Behavior therapy and sibutramine for the treatment of adolescent obesity","volume":"289","author":"Berkowitz","year":"2003","journal-title":"JAMA"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/GCO.0b013e3282efdc54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:39:52Z","timestamp":1786037992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001703-200710000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e3282efdc54","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}